Mergers and acquisitions continue to be strategic for growth, consolidation, and competitive advantage. In recent high-value transactions, global corporations and private equity firms have deployed over $15 billion to strengthen capabilities across financial software, energy infrastructure, professional services, and biopharma innovation.
Below are the top five M&A deals announced in the week ending January 11th, 2026. The data is curated from the Intellizence mergers & acquisitions Dataset.
Hg Capital Acquires OneStream for $6.4 Billion
Acquiring Company – Hg Capital
Acquired Company: OneStream
Deal Size: $6.4 billion
Industry: Financial Services
HG Capital has acquired OneStream, a leading provider of enterprise performance management (EPM) software, helping large organizations with financial consolidation, planning, forecasting, and reporting. Its platform is widely adopted by CFOs and finance teams in complex, global enterprises. This acquisition reflects growing demand for cloud-based financial intelligence platforms as enterprises modernize finance operations and comply with increasingly complex regulations.
The acquisition will help Hg Capital:
- Strengthen its portfolio in mission-critical enterprise software
- Provide exposure to recurring, high-margin SaaS revenues
- Position it to scale OneStream globally through operational expertise and bolt-on acquisitions
This deal underscores how data infrastructure is becoming foundational for enterprise AI adoption.
Vistra Corp. Acquires Cogentrix Energy for $4.7 Billion
Acquiring Company – Vistra Corp
Acquired Company – Cogentrix Energy
Deal Amount – $4.7 Billion
Industry: Energy / Power Generation
Vistra Corp. has acquired Cogentrix Energy, which owns and operates a diversified portfolio of natural gas and renewable power assets, supplying electricity across multiple U.S. markets, for $4.7 billion. The acquisition comes amid a growing need for reliable and flexible power generation, driven by data centers, electrification, and renewable integration.
The acquisition will help Vistra
- Expand its generation capacity and geographic footprint
- Enhance balance between conventional and renewable assets
- Improve long-term cash flow stability and grid reliability
Oakley Capital Acquires Majority Stake in Global Loan Agency Services for $1.3 Billion
Acquiring Company – Oakley Capital
Acquired Company – Global Loan Agency Services
Deal Amount – $1.3 billion
Industry: Financial Services
Oakley Capital will acquire majority stake in Global Loan Agency Services (GLAS), which provides independent loan agency and debt administration services to private credit funds, banks, and institutional lenders worldwide. With private credit markets expanding rapidly, demand for trusted third-party loan administration has surged.
The deal wil help Oakley Capital:
- Capitalize on structural growth in private debt markets
- Strengthen its exposure to asset-light financial services
- Create opportunities for international expansion and technology upgrades
Jacobs Acquires Remaining Stake in PA Consulting for $1.6 Billion
Acquiring Company – Jacobs
Acquired Company – PA Consulting
Valuation Amount – $1.6 Billion
Industry: Consulting / Engineering & Innovation
Jacobs has acquired remaining stake in PA Consulting that specializes in digital transformation, innovation, and strategy consulting, working with governments and enterprises across critical sectors. The move reflects growing convergence between engineering, technology, and consulting services as clients seek end-to-end transformation partners.
The acquisition will help Jacobs
- Deepen high-margin consulting capabilities
- Enhance digital, AI, and innovation advisory offerings
- Strengthen long-term client relationships beyond infrastructure projects
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion
Acquiring Company – Eli Lilly
Acquired Company – Ventyx Biosciences
Deal Amount – $1.2 Billion
Industry: Pharmaceuticals
Eli Lilly has acquired Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on immunology and inflammatory diseases, with promising drug candidates in development. Large pharmaceutical companies continue to acquire early-stage innovators to replenish pipelines and accelerate R&D.
The acquisition will help Eli Lilly:
- Strengthen its immunology drug pipeline
- Reduce internal development timelines
- Enhance long-term growth through differentiated therapies
Frequently Asked Questions
How does Intellizence track M&A deals?
Intellizence continuously monitors trusted global sources, including press releases, regulatory filings, stock exchange disclosures, company announcements, and credible news wires. Each deal is identified, validated, and structured into a standardized M&A signal.
Who uses the Intellizence M&A Dataset?
Investment firms, corporate strategy teams, consulting firms, sales & GTM teams, and AI/data platforms use Intellizence to identify opportunities and risks early.
What does “near real time” mean at Intellizence?
“Near real time” means that M&A deals are typically available on the Intellizence platform within 1–2 business days of the public announcement, after verification and enrichment to ensure accuracy and completeness.
Is Intellizence available via API?
Yes. Intellizence offers subscription-based and usage-based APIs to integrate M&A and other company signals directly into internal workflows, CRMs, and AI applications.
Who benefits from near real-time M&A signals?
- Sales & GTM teams identify high-intent accounts early
- Strategy teams track consolidation and market shifts
- Private equity & investment teams monitor deal activity
- Risk teams assess customer and vendor exposure
- AI & Data teams power automation and intelligence models
Refreshed Daily